Newstral
Jason Kolbert
- MSorrento Therapeutics stock is a buy on the 50% chance of a COVID-19 antidote, analyst saysmarketwatch.com
- MAdamis Pharma stock skyrockets after rival EpiPen product gets FDA approvalmarketwatch.com
- MBluebird Bio stock jumps 7% after Maxim Group upgrades to buymarketwatch.com
- Boston drug company Keryx continues to shake off the hatersbizjournals.com
- Here’s what it'll take for Boston biotech Keryx to ‘break the shorts’bizjournals.com
Frequent names
Newstral's extraction of names of people and organisations from the world's news is completely automated. If you do not want your name to appear here, please contact us. We will be happy to look at your request.